Literature DB >> 1577048

Eosinophil chemotactic activity of topical PAF on the human nasal mucosa.

H Klementsson1, M Andersson.   

Abstract

Ten patients with strictly seasonal allergic rhinitis were challenged with 132 micrograms PAF-acether in each nasal cavity outside their relevant pollen season. Cells from the nasal mucosa were collected by nasal lavage prior to and every second hour up to 8 h after the PAF challenge. At the same times the volume of methacholine-induced secretory responsiveness was measured. A brush specimen was harvested from the nasal mucosa prior to and 8 h after the PAF challenge. PAF led to an increase in the number of eosinophils from an initial 6.1 to 64.4 per glass 2 h later. The number of eosinophils in the nasal lavage fluid then decreased to its initial baseline value. By 8 h after PAF challenge the number of eosinophils collected with the brush was still elevated as compared to the initial brush sample (3.1 vs 24.1). PAF did not produce any change in methacholine-induced secretory responsiveness at any time. It appears that PAF possesses eosinophil chemotactic properties in the human nasal airway without altering the nasal secretory responsiveness. This confirms previous findings that the induction of nasal responsiveness is a more complex phenomenon than just the recruitment of eosinophils into the airway mucosa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577048     DOI: 10.1007/bf00266351

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophil influx.

Authors:  H Klementsson; M Andersson; U Pipkorn
Journal:  J Allergy Clin Immunol       Date:  1990-10       Impact factor: 10.793

2.  A brush method to harvest cells from the nasal mucosa for microscopic and biochemical analysis.

Authors:  U Pipkorn; G Karlsson; L Enerbäck
Journal:  J Immunol Methods       Date:  1988-08-09       Impact factor: 2.303

Review 3.  Platelet-activating factor as a mediator of allergic disease.

Authors:  P J Barnes; K F Chung; C P Page
Journal:  J Allergy Clin Immunol       Date:  1988-05       Impact factor: 10.793

4.  Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man.

Authors:  E Henocq; B B Vargaftig
Journal:  Lancet       Date:  1986-06-14       Impact factor: 79.321

5.  Effects of inhaled PAF in humans on circulating and bronchoalveolar lavage fluid neutrophils. Relationship to bronchoconstriction and changes in airway responsiveness.

Authors:  A J Wardlaw; K F Chung; R Moqbel; A J MacDonald; A Hartnell; M McCusker; J V Collins; P J Barnes; A B Kay
Journal:  Am Rev Respir Dis       Date:  1990-02

6.  The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment.

Authors:  R Bascom; U Pipkorn; L M Lichtenstein; R M Naclerio
Journal:  Am Rev Respir Dis       Date:  1988-08

7.  Effect of platelet activating factor on the human nasal mucosa.

Authors:  U Pipkorn; G Karlsson; B Bake
Journal:  Allergy       Date:  1984-02       Impact factor: 13.146

8.  Effect of platelet-activating factor on airway vascular permeability: possible mechanisms.

Authors:  T W Evans; K F Chung; D F Rogers; P J Barnes
Journal:  J Appl Physiol (1985)       Date:  1987-08

9.  Effect of disodium chromoglycate on changes in nasal airway resistance induced by platelet activating factor.

Authors:  G Karlsson; U Pipkorn
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Nasal methacholine challenge. A test for the measurement of nasal reactivity.

Authors:  P Borum
Journal:  J Allergy Clin Immunol       Date:  1979-04       Impact factor: 10.793

View more
  4 in total

1.  The use of the nose to study the inflammatory response of the respiratory tract.

Authors:  C G Persson; C Svensson; L Greiff; M Anderson; P Wollmer; U Alkner; I Erjefält
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

Review 2.  Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications.

Authors:  Rosa M Muñoz-Cano; Rocio Casas-Saucedo; Antonio Valero Santiago; Irina Bobolea; Paula Ribó; Joaquim Mullol
Journal:  J Clin Med       Date:  2019-08-29       Impact factor: 4.241

3.  Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design.

Authors:  Joaquim Mullol; Cesar Picado; Rosa Muñoz-Cano; Antonio Valero; Ignacio Izquierdo; Jaume Sánchez-López; Alejandro Doménech; Joan Bartra
Journal:  Allergy Asthma Clin Immunol       Date:  2013-11-01       Impact factor: 3.406

Review 4.  Mechanisms of nasal hyper-reactivity.

Authors:  M Andersson; L Greiff; C Svensson; C Persson
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.